Abstract | BACKGROUND AND OBJECTIVE: Several studies have analyzed big endothelin-1 as a marker of mortality in patients with severe heart failure (HF). However, it has not proven prognostic value in patients with moderately symptomatic functional class. Our objective was to evaluate, in a 24 months follow-up, the prognostic power of big endothelin-1 in patients with HF and moderately deteriorated functional class. MATERIAL AND METHOD:
Big endothelin-1 levels were measured in a cohort of 90 outpatients (age 64 (13), 70% males) diagnosed with HF. Patients were functionally classified (NYHA). RESULTS: For the whole population, big endothelin-1 was 0.86 (0.61-1.20)fmol/ml. We evaluated its predictive value in detecting cardiovascular mortality, obtaining an AUC of 0.68 (0.08) (P=.02), and a cut-off value of 0.98 fmol/ml (sensitivity 69%, specificity 75%). When a logistic regression analysis was performed, big endothelin-1 was also an independent predictor of mortality (OR=5.851, P=.009). CONCLUSIONS:
Big endothelin-1 predicts cardiovascular mortality in patients diagnosed of HF and moderately symptomatic functional class.
|
Authors | Esther Roselló-Lletí, Miguel Rivera, Vicente Miró, Raquel Cortés, Luís Martínez-Dolz, Manuel Portolés |
Journal | Medicina clinica
(Med Clin (Barc))
Vol. 133
Issue 5
Pg. 173-6
(Jul 04 2009)
ISSN: 0025-7753 [Print] Spain |
Vernacular Title | Valor pronóstico de big endotelina-1 en pacientes con insuficiencia cardíaca y clase funcional moderadamente sintomática. |
PMID | 19376546
(Publication Type: English Abstract, Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
|
Topics |
- Endothelin-1
(blood)
- Female
- Follow-Up Studies
- Heart Failure
(blood, classification, mortality, physiopathology)
- Humans
- Male
- Middle Aged
- Predictive Value of Tests
- Prognosis
- Prospective Studies
|